Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Margareta Mikkelsen.

Jinmin Miao1

  • 1Department of Medical Genetics, Biomedicum Helsinki, PO Box 63 (Haartmaninkatu 8), 00014 University of Helsinki, Finland. jinmin.miao@helsinki.fi

American Journal of Medical Genetics. Part A
|June 10, 2003
PubMed
Summary

Pioneering cytogeneticist Margareta Mikkelsen established Denmark's first chromosome labs and advanced Down syndrome research. Her work trained a generation of clinical geneticists and pioneered prenatal diagnosis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Protein Tyrosine Phosphatase 4A1 (PTP4A1) Regulates Early Events in Colorectal Cancer Intraperitoneal Dissemination in the Aged Male Host.

Aging and cancer·2026
Same author

Discovery of a First-in-Class Covalent Allosteric SHP1 Inhibitor with Immunotherapeutic Activity.

Angewandte Chemie (International ed. in English)·2025
Same author

Synergistic effects of deleting the tyrosine phosphatases Shp1 and Shp2 on megakaryopoiesis and thrombopoiesis in mice.

bioRxiv : the preprint server for biology·2025
Same author

Structure-activity relationship studies and design of a PTPN22 inhibitor with enhanced isozyme selectivity and cellular efficacy.

European journal of medicinal chemistry·2024
Same author

Discovery and evaluation of novel SHIP-1 inhibitors.

Bioorganic & medicinal chemistry·2024
Same author

Off-target autophagy inhibition by SHP2 allosteric inhibitors contributes to their antitumor activity in RAS-driven cancers.

The Journal of clinical investigation·2024

Area of Science:

  • Human Genetics
  • Cytogenetics
  • Medical Ethics

Background:

  • Margareta Mikkelsen pioneered autosome aberration research in 1959.
  • Established Denmark's first chromosome laboratory at the University of Copenhagen.
  • Developed a leading chromosome laboratory at the John F. Kennedy Institute (JFKI) in 1968, serving diagnostic and training needs nationwide.

Discussion:

  • Dr. Mikkelsen's primary research focus was Down syndrome (DS), investigating the origins of trisomy 21.
  • She performed Denmark's first prenatal diagnosis via amniocentesis, significantly impacting genetic screening.
  • The JFKI, under her influence, also engaged in research on fragile X syndrome.

Key Insights:

  • Mikkelsen's leadership in establishing clinical genetics infrastructure and training in Denmark was foundational.
  • Her research contributions to Down syndrome and prenatal diagnosis advanced the field significantly.
  • She was a prominent figure in public education and scientific organizations across Denmark and Europe.

Outlook:

  • Dr. Mikkelsen's legacy includes a generation of trained geneticists and advancements in diagnostic capabilities.
  • Her later engagement in medical ethics highlights a continued commitment to the broader implications of genetic science.
  • Her life story exemplifies resilience and dedication in the face of personal and historical adversity.

Related Experiment Videos